Format
Sort by

Send to

Choose Destination

Links from PubChem BioAssay

Items: 9

1.

Cell growth control: little eukaryotes make big contributions.

De Virgilio C, Loewith R.

Oncogene. 2006 Oct 16;25(48):6392-415. Review.

PMID:
17041625
2.

The TOR signalling network from yeast to man.

De Virgilio C, Loewith R.

Int J Biochem Cell Biol. 2006;38(9):1476-81. Review.

PMID:
16647875
3.

TOR signaling in growth and metabolism.

Wullschleger S, Loewith R, Hall MN.

Cell. 2006 Feb 10;124(3):471-84. Review.

4.

Drosophila target of rapamycin kinase functions as a multimer.

Zhang Y, Billington CJ Jr, Pan D, Neufeld TP.

Genetics. 2006 Jan;172(1):355-62.

5.

High throughput flow cytometry.

Kuckuck FW, Edwards BS, Sklar LA.

Cytometry. 2001 May 1;44(1):83-90.

PMID:
11309812
6.

The Rho1 effector Pkc1, but not Bni1, mediates signalling from Tor2 to the actin cytoskeleton.

Helliwell SB, Schmidt A, Ohya Y, Hall MN.

Curr Biol. 1998 Nov 5;8(22):1211-4.

7.

Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity.

Cafferkey R, Young PR, McLaughlin MM, Bergsma DJ, Koltin Y, Sathe GM, Faucette L, Eng WK, Johnson RK, Livi GP.

Mol Cell Biol. 1993 Oct;13(10):6012-23.

8.

Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression.

Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Movva NR, Hall MN.

Cell. 1993 May 7;73(3):585-96.

PMID:
8387896
9.

Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.

Stan R, McLaughlin MM, Cafferkey R, Johnson RK, Rosenberg M, Livi GP.

J Biol Chem. 1994 Dec 23;269(51):32027-30.

Items per page

Supplemental Content

Support Center